Dupixent Lymphoma Lawsuit Eligibility: Who May Qualify in 2026

If you used Dupixent (dupilumab) and were later diagnosed with cutaneous T-cell lymphoma (CTCL), you may be able to bring a claim in the federal litigation now pending in New Jersey. Eligibility turns on three things a lawyer will check first: documented Dupixent use, a pathology-confirmed CTCL diagnosis, and a filing deadline that has not run out in your state.

My read is that this is an early, unsettled case. There is no settlement, causation is disputed, and anyone promising you a number is selling something. What follows is how the process actually works, so you can decide whether a consultation is worth your afternoon.

What is the Dupixent cutaneous T-cell lymphoma MDL?

On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the first group of federal cases, 15 actions at that point, into MDL No. 3180 in the U.S. District Court for the District of New Jersey, assigned to Judge Zahid N. Quraishi, according to the JPML transfer order and legal trade reporting. Defendants named in that reporting are Regeneron Pharmaceuticals and Sanofi-Aventis U.S., and some trackers also list Genzyme. The docket has been growing, so check the court’s page for current numbers.

An MDL is a filing-cabinet decision, not a verdict. A single judge handles discovery and pretrial motions for similar cases so the companies are not litigating the same questions in dozens of courts. The panel’s scope is cutaneous T-cell lymphoma; whether other T-cell lymphomas belong was left open, per the reporting I reviewed.

The central allegation is that dupilumab may be linked to CTCL, sometimes in patients whose skin condition was treated as severe eczema before the lymphoma was identified. The manufacturers dispute that the drug causes lymphoma. Neither side has won that argument in court yet.

Dupixent lymphoma lawsuit eligibility: who may qualify?

Here is the checklist I would run through before calling a firm. None of these is a legal guarantee; they are the questions an intake team asks.

Question	Why it matters	Typical proof
Did you use Dupixent (dupilumab)?	Proves exposure to the drug	Pharmacy fill history, prescription records
Was it prescribed for eczema, asthma or another approved use?	Establishes the treatment context	Doctor notes, insurance claims
Were you diagnosed with cutaneous T-cell lymphoma?	The MDL is built around CTCL	Biopsy and pathology report
Did the diagnosis come after you started the drug?	Sequence matters for causation arguments	Dated records showing both
Was the diagnosis recent enough to file?	State deadlines can bar late claims	Diagnosis date, discovery date
Do you have other lymphoma risk factors?	Defendants will raise them	Full medical history

Notice what is not on the list: a particular dose, a minimum number of months, or a specific age. Those details shape how strong a case is, not whether you can ask. If you are wondering whether you qualify for a Dupixent lawsuit, the honest answer is that only a lawyer reviewing your records can say.

One complication deserves attention. CTCL can look like eczema in its early stages, and some patients are misdiagnosed for a time. Defendants may argue the lymphoma was already there when Dupixent started, which is a causation fight, not an eligibility bar. Your dermatology history will be read closely.

Is this a class action, and what does that change for you?

It is not. In a class action, a court certifies one group and the outcome binds everyone in it. In an MDL, every plaintiff files an individual lawsuit that is simply coordinated with the others. Your claim stands or falls on your own records.

Practically, that means three things. You must retain a lawyer or file yourself, since nobody is automatically enrolled. Any eventual settlement, if one ever comes, would be negotiated for specific plaintiffs and allocated by facts. And “bellwether” trials, test cases chosen from the pool, may eventually shape how others are valued. I have not seen any reliable report of one being scheduled yet, so treat any such claim as unverified.

What happens step by step, and how long does it take?

MDLs run slowly. Years, not months, is the norm for pharmaceutical dockets. Here is the usual sequence.

1. Gather your pharmacy, prescription and pathology records.
2. Consult a product-liability lawyer, ideally two, and compare fee terms.
3. Sign a fee agreement and a records authorization.
4. The firm confirms the diagnosis and Dupixent timeline, then files in or transfers to the MDL.
5. Plaintiffs typically complete fact sheets or similar disclosures.
6. Pretrial motions and expert fights on causation play out before the MDL judge.
7. Selected test cases may go to trial, and the results can push the parties toward talks, or not.

Stage	What you do	Rough pace
Record gathering	Request pharmacy and medical records	Weeks, depending on providers
Intake and agreement	Talk to counsel, sign documents	Days to weeks
Filing	Lawyer files the complaint	Weeks after retention
Discovery and expert phase	Respond to fact sheets and requests	Often a year or more
Test cases	Mostly wait	Uncertain; no verified schedule found
Resolution	Decide on any offer	Unknown; no settlement reported

For a sense of how a federal product MDL moves, see our post on the Exactech knee and hip recall MDL you can see how a device MDL moves, the sequence is similar here.

Do I qualify for a Dupixent lawsuit if my records are incomplete?

Often, yes, the gap can be fixed. Pharmacies and insurers keep fill histories for years, and a lawyer can send authorizations to clinics and pathology labs. What cannot be fixed is a deadline that has already passed, which is why speed beats tidiness here. Start with the diagnosis letter and the name of your pharmacy.

How much does a Dupixent lawyer cost?

Most firms taking drug-injury cases work on contingency: no fee unless they recover something. The percentage, and whether case costs such as experts and records come out before or after the fee, differs from firm to firm. I would not hire anyone who will not put both in writing before you sign.

Questions worth asking: does the firm have prior MDL experience, who will actually handle your file, and what happens to costs if you recover nothing? Our guide to lawyer consultation costs walks through free consultations and fee agreements in more detail, and the contingency logic is the same one you see in an Uber accident case.

What mistakes cost people their Dupixent claim?

• Waiting. State statutes of limitations vary, and the clock often runs from when you knew or reasonably should have known of the injury and a possible cause. Waiting for “more news” is the classic way to lose a case.
• Throwing away records, or never asking for the biopsy report.
• Quitting the drug without a doctor. That is a medical risk, and it does not help your case.
• Trusting a website that lists payout ranges. There is no settlement, so any range is invented.
• Signing with the first firm that calls you after a lead-generation form.
• Posting about your diagnosis publicly while the case is open. Defense lawyers read social media.

A failure story I have seen repeated in forums: a reader was diagnosed with CTCL, spent a year on treatment, and only then began asking about a claim. By the time records were requested, one clinic had closed and the pharmacy history was incomplete. The case was still possible but much harder. Records requests take time; start them early.

If your situation is a different kind of injury entirely, such as a workplace one, the process looks different, and our pieces on workers’ compensation claims and Social Security disability lawyers cover those tracks. Lymphoma can also affect your ability to work, which sometimes opens the disability route in parallel.

Should I stop Dupixent because of the lawsuit?

No, not without your doctor. Dupixent treats real conditions, and stopping can bring symptoms back or make them worse. If a rash is changing, not responding to treatment, or you have new lumps or persistent itching, tell your dermatologist and ask whether a biopsy is appropriate. That is medical advice you should get from your clinician, and it protects both your health and your documentation.

My bottom line

If you have a pathology-confirmed CTCL diagnosis and a Dupixent history, a consultation is reasonable and usually free. Bring the records, ask about fees in writing, and expect a long, uncertain road with no promised outcome. Everything else is noise.

This article is general information, not legal advice, and does not create an attorney-client relationship. Litigation facts change; verify the current status with the court and consult a licensed attorney about your situation.